Application progress of telemedicine in bipolar disorder patients under the COVID-19 pandemic
3rd International Symposium on Artificial Intelligence for Medical Sciences, ISAIMS 2022
; : 243-246, 2022.
Article
in English
| Scopus | ID: covidwho-2194147
ABSTRACT
Bipolar disorder (BD) is a highly pathological disorder that is often misdiagnosed or undiagnosed. The main treatment is a combination of psychotherapy and medication. Traditional psychotherapy is affected by factors such as time, space, shortage of professional psychotherapists and patients' stigma, and has low availability. In terms of drug therapy, patients' medication compliance is poor, leading to repeated illness. The epidemic of coronavirus in 2019, closed management and telemedicine provide new ideas for the treatment of BD. Telemedicine can provide convenient medical services, promote disease rehabilitation, effectively guide patients' self-management, improve patients' treatment compliance, and prevent disease recurrence. This paper analyzes and summarizes the research related to telemedicine in BD, including the origin and significance, technical methods and application effects. To provide a reference for the application of telemedicine in patients with BD. © 2022 ACM.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Language:
English
Journal:
3rd International Symposium on Artificial Intelligence for Medical Sciences, ISAIMS 2022
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS